Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.0650
-0.0050 (-7.14%)
Jul 21, 2026, 11:31 AM EST
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $31.03 million as of July 21, 2026. Its market cap has decreased by -75.22% in one year.
Market Cap
31.03M
Enterprise Value
22.78M
Revenue
34.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
ChartMarket Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 31.03M, a decrease of -66.40%. That is a compound annual growth rate of -4.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 31.03M | -78.04% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuo Therapeutics | 48.41M |
| Vicapsys Life Sciences | 47.26M |
| Arch Biopartners | 40.99M |
| ProText Mobility | 33.41M |
| BetterLife Pharma | 26.06M |
| Provectus Biopharmaceuticals | 25.41M |
| EOM Pharmaceuticals Holdings | 18.98M |
| Oncotelic Therapeutics | 18.22M |